Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
10/2001
10/24/2001CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
10/24/2001CN1318372A Application of insulin sensitizing agent in treatment of nephrosis
10/24/2001CN1073561C Alkyl sulphinyl and alkyl sulphonyl-1,2,4-thiadiazolyloxy acetamides and their use as herbicides
10/23/2001US6307064 Process to prepare taxol
10/23/2001US6306890 Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
10/23/2001US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001US6306877 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
10/23/2001US6306871 Iodonitrobenzamide derivatives as anticarcinogenic, antitumor agents and viricides
10/23/2001US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones
10/23/2001US6306840 Cell adhesion inhibitors
10/23/2001CA2108064C Thiazolidine dione compounds, process for preparing same and pharmaceutical compositions containing same
10/23/2001CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
10/23/2001CA2062788C Improved process for preparing isepamicin
10/18/2001WO2001077092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/18/2001WO2001077091A2 Ns5b hcv polymerase inhibitors
10/18/2001WO2001077077A1 Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
10/18/2001WO2001076390A2 Flavouring a foodstuff with compounds containing a sulfur atom linked to two specific atoms or groups
10/18/2001US20010031896 By reacting with 2,2,2-trifluoroethylformate in an optionally buffered solvent; by-product inhibition
10/18/2001US20010031876 Reacting amine substituted benzothiazolone with a sulfone
10/18/2001US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001US20010031759 Novel heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
10/18/2001US20010031752 Administered as anorexigenic agents, dietetics, antidiabetics and for enhancing lipid metabolism
10/18/2001US20010031730 Method for treatment of glutamate related disorders
10/18/2001CA2405145A1 Flavouring a foodstuff with compounds containing a sulfur atom linked to two specific atoms or groups
10/18/2001CA2372352A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/17/2001EP1146037A1 Process for the preparation of optically active amino alcohols
10/17/2001EP1144399A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
10/17/2001EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
10/17/2001EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
10/17/2001EP1144393A2 Heterocyclic derivatives and their use as integrin inhibitor
10/17/2001EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
10/17/2001EP1144385A1 Benzoheterocycles and their use as mek inhibitors
10/17/2001EP1144375A2 Synthesis of oligoketides
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1143951A2 Antimalarial agents
10/17/2001EP1143943A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
10/17/2001EP1143916A2 Topical compositions comprising protected functional thiols
10/17/2001EP0950049B1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
10/17/2001CN1318061A Thiazolylcinnamonitriles and pest controlling agents
10/17/2001CN1318054A Novel compounds
10/17/2001CN1073099C Process for producing internecliates used in process for producing 2-iminothiazoline derivatives
10/17/2001CN1073098C Benzothiazolone derivatives
10/17/2001CN1073097C Aniline derivatives having herbicidal activity their prepn. and their use
10/17/2001CN1073096C Process for prepn. of 2-chloro-5-cholromethyl-1,3-thiazole
10/17/2001CN1073095C Process for prepn. of nizatidine
10/17/2001CN1073094C Process for preparing benzyl-sustituted rhodanine derivatives
10/16/2001US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/16/2001US6303661 Orally administering inhibitor of dipeptidyl peptidase (dp iv) or of dipeptidyl peptidase iv-like activity
10/16/2001US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative
10/16/2001US6303640 Administering oxazole or thiazole derivative compound for reducing side effects of diabetic therapy
10/16/2001US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors
10/16/2001US6303342 Recombinant methods and materials for producing epothilones C and D
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074795A1 Process for preparing amic acid esters
10/11/2001WO2001074794A1 Process for producing substituted alkylamine derivative
10/11/2001WO2001074793A2 Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1
10/11/2001WO2001074788A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/11/2001WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001WO2001074761A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
10/11/2001WO2001074757A1 Process for the selective n-formylation of n-hydroxylamines
10/11/2001WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
10/11/2001WO2001074506A1 Extrusion die
10/11/2001WO2001002377A9 Telomerase inhibitors and methods of their use
10/11/2001WO2000016763A3 Antimalarial agents
10/11/2001DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate
10/11/2001CA2405132A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/11/2001CA2404628A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
10/11/2001CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001CA2403885A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001CA2403529A1 Process for the selective n-formylation of n-hydroxylamines
10/10/2001EP1142885A1 Novel 2-(n-cyanoimino)thiazolidin-4-one derivatives
10/10/2001EP1142872A1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/10/2001EP1142868A1 Amide derivatives
10/10/2001EP1142867A2 Cell adhesion inhibitors
10/10/2001EP1142490A1 Flavouring a foodstuff with compounds containing a sulphur atom linked to two specific atoms or groups
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001EP1140846A1 Aspartic protease inhibitors
10/10/2001EP1140819A1 Alfa-sulfenimino acid derivatives
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140791A2 Selective cpla 2 inhibitors
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140768A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
10/10/2001EP1140080A1 Use of riluzole for treating acoustic traumas
10/10/2001EP1140066A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001CN1316986A Novel compounds
10/10/2001CN1316418A Benzene sulfonic derivative
10/10/2001CN1072655C New Heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical composition containing their
10/10/2001CN1072654C Benzamide derivative, composition containing said derivative and use thereof
10/10/2001CN1072653C Improved effect thifluzamide
10/10/2001CN1072652C Substd benzoylaminothizole derivatives and drugs containing same
10/10/2001CN1072651C Intermediates for preparation of 2-imidzaoline-5-ones
10/09/2001US6300519 Antivirally active heterocyclic azahexane derivatives
10/09/2001US6300372 3-Cyano-3-(3,4-disubstituted) phenylcyclohexyl-1-carboxylates
1 ... 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 ... 337